#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arterial tortuosity syndrome Craniopharyngioma Palmar-plantar erythrodysaesthesia syndrome Fms-like tyrosine kinase 3 positive Fungal infection Non-small cell lung cancer Iron overload Immune-mediated renal disorder Aplastic anaemia T-cell type acute leukaemia Thalassaemia beta Craniocerebral injury Penile cancer Cerebral amyloid angiopathy Hydrocephalus More trials…

    Learn about Rare Diseases

    Small intestine leiomyosarcoma – Treatment Primary mediastinal large B-cell lymphoma – Diagnostics Hepatoblastoma – Treatment Haemophilia B with anti factor IX – Diagnostics Hypereosinophilic syndrome Splenic marginal zone lymphoma – Life with Disease Congenital hypotransferrinaemia – Trials in Disease Piriformis syndrome – Diagnostics Systemic mastocytosis – Life with Disease Mitochondrial myopathy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clomipramine Hydrochloride TRIACYLGLYCEROL LIPASE Db-1303 Alx148 Autologous Microfat Pemigatinib Carisbamate Umeclidinium Bromide Orlistat Ixazomib Tirzepatide Ofatumumab Sildenafil BROLUCIZUMAB Pirtobrutinib Fexofenadine Hydrochloride Zinc Sulphate Heptahydrate Fadraciclib Fulvestrant Citric Acid More therapies…

    Learn about Your Condition

    Diabetic neuropathy Pneumonia bacterial Procedural pain Cushing's syndrome Osteopenia Postoperative delirium Bladder cancer stage II Carcinoid tumour pulmonary Myocarditis post infection Osteochondrodysplasia Oesophageal carcinoma Dry eye Choroidal dystrophy Benign prostatic hyperplasia Mucopolysaccharidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Overweight

  • Study on the Effects of Semaglutide for Weight Management in Children and Adolescents with Obesity or Overweight

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Denmark Germany Portugal Sweden

  • Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Ertugliflozin
    • Insulin Glargine
    Austria Czechia Germany Greece Italy Romania +2

  • Study on the Effects of AZD5004 for Adults with Obesity or Overweight and a Related Medical Condition

    Not recruiting

    2 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Azd5004
    Germany

  • A Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Germany Hungary Ireland Poland

  • Study on the Effectiveness of Orforglipron for Patients with Obstructive Sleep Apnea and Obesity or Overweight

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • 3-((1S,2S)-1-(5-((S)-2,2-Dimethyltetrahydro-2H-Pyran-4-Yl)-2-((S)-3-(3-(4-Fluoro-1-Methyl-1H-Indazol-5-Yl)-2-Oxo-2,3-Dihydro-1H-Imidazol-1-Yl)-2-(4-Fluoro-3,5-Dimethylphenyl)-4-Methyl-4,5,6,7-Tetrahydro-2H-Pyrazolo[4,3-C]Pyridine-5-Carbonyl)-1H-Indol-1-Yl)-2-Methylcyclopropyl)-5-Oxo-1,2,4-Oxadiazol-4-Ide Hemicalcium
    Czechia Germany

  • Study of Tirzepatide and Placebo for People with Overweight or Obesity and Chronic Kidney Disease, with or without Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    • Obesity
    Investigated Drugs:
    • Iohexol
    • Tirzepatide
    Austria Denmark The Netherlands
Previous Page
1 … 5 6 7

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!